European Archives - Page 208 of 1448 - European Medical Journal

supplements

Supplement Labels Overstate Heart Health Benefits, Study Finds

Survey finds supplement labels mislead consumers into thinking products prevent disease, prompting calls to tighten regulatory standards.

PSA

Repeating Prostate-Specific Antigen Tests May Prevent Unnecessary Prostate Biopsies

A predictive scoring system, incorporating both current and prior PSA values, revealed that patients with persistently elevated levels had a very low likelihood, under 10%, of their PSA decreasing below the threshold at follow-up.

Gold coins on blue background

Sanofi commits $625m to Sanofi Ventures

Sanofi has committed $625m to its corporate venture capital arm, Sanofi Ventures, for funding biotech and digital health companies.

PET-MRE Shows Promise in Monitoring Crohn’s Disease Treatment

PET-MRE significantly reduced SUVMax and inflammation markers in small bowel Crohn’s disease.

ageing

New Blood Test Tracks Ageing Across the Body

Scientists develop a blood test that measures aging across 11 body systems, offering more precise insights into health risks.

Rapid AI-Driven Leukaemia Diagnosis Revolutionises Treatment Urgency

Innovative AI tool MARLIN classifies leukemia fast and accurately, improving urgent treatment decisions.

AI-Enhanced Approaches to Interstitial Lung Disease

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, and prognosis, especially for idiopathic pulmonary fibrosis.

Tirzepatide Diet-related quality of life

Tirzepatide May Boost Diet-Related Quality of Life in Diabetes

Learn how tirzepatide treatment improves diet-related quality of life and satisfaction in Type 2 diabetes patients.

Standardising Patch Testing for Children with Contact Dermatitis

Findings revealed that 17 allergens, already part of the adult EBS, produced positive reactions in at least 1% of children.

Two doctors discussing social media, with one holding an iPad

Social media: What pharma needs to know in 2025

From listening in real time to outpacing the algorithm, these four trends show how marketers can succeed on social.